仁和药业股份有限公司 关于变更签字注册会计师的公告

Core Viewpoint - The company has approved the appointment of Beijing Dahua International Accounting Firm as its auditing institution for the fiscal year 2024, following the approval from the 2023 annual shareholders' meeting [1]. Group 1: Change of Accounting Firm - The company held its 18th board meeting and 12th supervisory board meeting on April 24, 2024, where the proposal to change the accounting firm was approved [1]. - The announcement regarding the change of the accounting firm was disclosed on April 26, 2024, in various financial publications and on the official website [1]. Group 2: New Auditor Information - The signing auditor, Wang Jiwen, has been a certified public accountant since June 1994 and has been involved in auditing listed companies since 1998. He will start providing auditing services to the company in 2024 [3]. - The new signing project partner, Ding Li, has been a certified public accountant since February 1994 and has been engaged in auditing listed companies since December 1996. She will also begin providing auditing services in 2024 [9]. Group 3: Transition and Independence - The transition process for the change of auditors has been orderly, and it is stated that this change will not affect the company's financial statements and internal control audits for 2024 [4]. - The new auditing firm, Beijing Dehao International Accounting Firm, and its personnel have no issues regarding independence and integrity as per the professional ethical standards [10].